Mutations in different components of FGF signaling in LADD syndrome
Edyta Rohmann(University of Cologne), Bernd Wollnik(University of Cologne), Hans van Bokhoven(Radboud University Nijmegen), Hülya Kayserili(Istanbul University), Gudrun Nürnberg(University of Cologne), Abdullah Üzümcü(Istanbul University), Erin D. Lew(Yale University), Zehra Oya Uyguner(Istanbul University), Angus Dobbie(St James's University Hospital), Veraragavan P. Eswarakumar(Yale University), Joseph Schlessinger(Yale University), Melike Ulubil-Emeroglu(Istanbul University), Peter Nürnberg(Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases), Kai Lehnerdt(Klinikum Dortmund), Yun Li(University of Cologne), Christian Becker(University of Cologne), Han G. Brunner(Radboud University Nijmegen), Cor W. R. J. Cremers, Memnune Yüksel‐Apak(Istanbul University), Jules G. Leroy(Ghent University Hospital), Christian Kubisch(Universität Hamburg)
Cited by 209
Related Papers
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
|Nature|2010|1.8k
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
|Nature Genetics|2006|1.2k
A Potassium Channel Mutation in Neonatal Human Epilepsy
|Science|1998|1.1k
Phosphatidylinositol 3′‐kinase is activated by association with IRS‐1 during insulin stimulation.
|The EMBO Journal|1992|1k